Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|36|10|1450-1456

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.36, Iss.10, 2016-10, pp. : 1450-1456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Obesity is independently associated with infection in hospitalised patients with end‐stage liver disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 11-12, 2015-12 ,pp. : 1271-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 459-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obesity paradox in cirrhosis: is it real or just an illusion?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 36, Iss. 10, 2016-10 ,pp. : 1412-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 704-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 584-590

John Wiley & Sons Inc

Access to resources Recommend Favorite